Durvalumab and Tremelimumab in Patients With Advanced Rare Tumours
Clinical trial NCT02879162 · COMPLETED
Trial details
- NCT number
- NCT02879162
- Sponsor
- Canadian Cancer Trials Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-14
- Primary completion
- 2021-06-20
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.